应重点实验室徐福建教授课题组邀请, The Ohio State University的Prof. Peixuan Guo于2017年9月6日到访实验室并为我校师生作了题为“Studies on viral DNA packaging motor that lead to the discovery of the third type of Biomotor with revolving, the use of motor nanochannel for single pore sensing, and the emergence of a new field of RNA nanotechnology”的学术报告。
在此次报告中，Prof. Peixuan Guo重点介绍了基于DNA生物纳米马达的研究现状，同时也讲解了基于RNA在纳米治疗中的挑战与未来。Prof. Peixuan Guo的报告让老师和同学们更加深入的了解了纳米材料在新型重大疾病诊疗的重要性，同时也了解了合成新结构和新功能高分子对聚合物科学发展的重要意义。最后，在提问环节中，Prof. Peixuan Guo和在座师生进行了交流互动。
Prof. Peixuan Guo简介：
Dr. Guo received his Ph.D. in Microbiology and Genetics from University of Minnesota in 1987. After a postdoc at NIH he joined Purdue in 1990, tenured in 1993, and awarded a Purdue Faculty Scholar in 1998 with a rank of full professor. He founded two interdisciplinary graduate programs and established the NIH Nanomedicine Development Center at Purdue. In 2007, he served as University of Cincinnati as the Endowed Chair of Biomedical Engineering and director of the NIH Nanomedicine Development Center. In 2012, he served as University of Kentucky Endowed Chair in Nanobiotechnology, directing both the Nanobiotechnology Center and the NCI Cancer Nanotechnology Platform Partnership Program. In 2016 he joined Ohio State University as the Endowed Chair in Pharmaceutics and Drug Delivery, and directs the Center for RNA Nanobiotechnology and Biomedicine. Dr. Guo’s work is widely reported. He is well known for constructing the first viral DNA packaging motor in vitro (PNAS, 1986), discovering the phi29 motor pRNA (Science 1987), assembling the first infectious dsDNA viruses using synthetic and purified components, and discovering the pRNA hexamer (Molecular Cell, 1998;, EMBOJ 2007). He is the pioneer of RNA nanotechnology, receiving many honors including the Pfizer Distinguished Faculty Award; the Purdue Faculty Scholar award; the Lions Club Cancer Research Award; Distinguished Alumni of University of Minnesota; and 100 Years Distinguished Chinese Alumni of the University of Minnesota. He is editor or board of many nanotech journals, and the member of three prestigious NIH, NSF, NIST and National Science & Technology Council Nanobiotechnology initiatives.
